Trademarkia Logo

Canada

C$
Trademark Search in Canada
LIFE BIOSCIENCES

View On IC.GC.CA

LIFE BIOSCIENCES
OPPOSED

on 20 Jul 2023

Last Applicant/ Owned by

Life Biosciences Inc.

31 Saint James Avenue6th FloorBoston, MA 02116-4128

US

Serial Number

1905896 filed on 22nd Jun 2018

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

LIFE BIOSCIENCES

Trademark usage description

pharmaceutical preparations for the treatment of eye diseases, namely glaucoma, retinitis pigmentosa, retinal disorders, and age-related macular degen Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of eye diseases, namely glaucoma, retinitis pigmentosa, retinal disorders, and age-related macular degeneration; pharmaceutical preparations for the treatment of skin diseases, namely wrinkles, thinning of epidermis, thinning of dermis, loss of subcutaneous fat, loss of skin elasticity, elastosis, poor wound healing, skin tears, skin tags, decubitus ulcers, senile purpura, skin dryness, actinic keratoses, seborrheic keratoses, and burns; pharmaceutical preparations for the treatment of osteoarthritis; pharmaceutical preparations for the treatment of disorders of the central and peripheral nervous system, namely spinal cord injury and neuropathy; pharmaceutical preparations for the treatment of organ injury, namely kidney and heart; pharmaceutical preparations for the treatment of haematologic disorders; pharmaceutical preparations for the treatment of hearing loss; pharmaceutical preparations for the treatment of metabolic diseases, namely obesity, diabetes, insulin resistance, and liver diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely dementia, frontotemporal dementia, immunosenescence, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, ALS, stroke, ischemia reperfusion injury, and traumatic brain injury; neutraceuticals and cosmeceuticals in the form of dietary and nutritional supplements for reducing the signs of aging (namely skin and hair aging), treating immunological diseases and degenerative conditions of the body (namely obesity, inflammation, and liver disease), promoting general health and well being for life extension, and restoring youthful bodily function (namely treating muscle and joint pain).

Classification kind code

11

Class [035]
Business management consulting and assistance, business advisory services, namely advice re business planning, analysis, strategy, organization, financing, marketing and management

Classification kind code

11

Class [042]
Research and development services in the field of diseases, disorders, and degenerative conditions associated with aging; Research and development services in the fields of chronic diseases, conditions and functional disorders; Scientific research services in the field of gene therapy; Platform as a service (PAAS) featuring software platforms for aggregating, analyzing and disseminating scientific and medical research data

Classification kind code

11

Class [044]
Medical diagnostics services; medical services for the diagnosis of diseases, disorders and degenerative conditions associated with aging; providing information in the field of medical diagnostics; providing information relating to diagnosis and monitoring of chronic diseases, conditions and functional disorders

Classification kind code

11

Mark Details

Serial Number

1905896

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 20th Apr 2022		Advertised
Submitted for opposition 26
on 10th Feb 2022		Approved
Submitted for opposition 27
on 10th Feb 2022		Approval Notice Sent
Submitted for opposition 15
on 21st Apr 2021		Correspondence Created
Submitted for opposition 22
on 22nd Jun 2020		Search Recorded
Submitted for opposition 20
on 22nd Jun 2020		Examiner's First Report
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 31
on 3rd Jul 2018		Formalized
Submitted for opposition 1
on 26th Jun 2018		Created
Submitted for opposition 30
on 22nd Jun 2018		Filed